ABSTRACT OBJECTIVES This study sought to determine the variation in annual health care costs among patients with heart failure in the Veterans Affairs (VA) system. BACKGROUND Heart failure is associated with considerable use of health care resources, but little is known about
H eart failure (HF) is associated with considerable morbidity and mortality, and patients diagnosed with this condition use a significant amount of health care resources. The economic burden of HF, especially in aging adults, is substantial: Medicare costs for all care for advanced HF patients have been estimated to be $36,216 in the final 6 months of life (1, 2) . One key driver of costs for HF patients is the high rate of hospitalizations (3) .
A study of patients hospitalized for HF (4) found that they had an average of $7,100 in costs over the following 6 months with one-half of them being was found to increase costs in HF patients by 26%
to 29% because of greater inpatient and outpatient utilization, but not significantly greater mental health utilization (5) . Other psychiatric conditions such as alcohol disorders and bipolar disorder have also been related to higher costs (6) .
In addition to patient factors such as comorbidity, variation in treatment patterns by providers also contributes to the utilization of HF patients. Previous research looked at small-area geographic variation and between-hospital variation in quality measures for patients hospitalized for HF. These studies found substantial variation in quality measures as well as length of stay and mortality; some of this variation was explained by provider and hospital characteristics, such as teaching status of hospitals (7, 8) . system. The VA health care system cares for more than 5 million patients each year, and HF is present in many multimorbid patients, especially among the highest cost patients in the system (9). Using national performance measures of quality of care and paying providers on a salary basis may potentially minimize geographic and provider differences in the VA system.
Examining variation in health care costs between HF patients can shed light on the factors that are associated with higher costs and can also serve as potential areas to target for quality improvement. In this study, we aimed to determine the variation in 1-year, VA health care costs in a population of patients diagnosed with HF. We compared the differences in costs between patients by sociodemographic factors, comorbid conditions, geographic location, and the facility where patients were treated. We also determined the specific types of inpatient and outpatient health care services that patients used. and model 3 included all patient factors and facility dummies. We compared the R 2 and root mean squared error of the 3 models to determine whether the variation in health care costs was explained predominantly due to patient characteristics or facility where patients were treated (22) .
METHODS
We also used our fully adjusted regression model to compare the mean cost per HF patient in each facility after controlling for patient characteristics.
For each facility, predicted cost per patient was estimated using regression model estimates for that facility and divided by the predicted cost per patient across all facilities and multiplied times the unadjusted cost per patient across all facilities to obtain the mean adjusted cost in each facility.
RESULTS
Among the 5,233,994 patients who received any VA care in FY2010, there were 117,870 patients, or 2.3%, who were identified as having HF. The majority of HF patients (56%) were age 70 years and older, and few were younger than 50 years of age ( Table 1) .
Patients were predominantly male (98%), and most patients were white (77%), whereas another 17% were black, 4% were Hispanic, and the rest were from other or unknown racial/ethnic groups. Only 53% of HF patients were currently married, and most patients were below the VA means test for eligibility or had a service-connected disability.
Because of the older age of many HF patients, most
were covered by Medicare. By geographic region, there was a higher percent of all HF patients from the Midsouth region, which included the Texas network.
There was high prevalence of many chronic conditions among the study cohort. Hypertension was the most prevalent condition, diagnosed among 76% of HF patients in the current year. Ischemic heart disease (53%), diabetes (46%), and renal failure (21%)
were also common diagnoses. In our cohort of HF patients, 10% died during the year.
The study cohort had mean annual VA costs of Health care costs not only varied by the type of care, but they also varied by demographic factors, comorbidity, and geographic location. Patients age 50
to 59 years of age had the highest mean health care costs (Online Figure 1) , as VA health care costs declined for older ages because they were eligible for Medicare. Patients of different racial/ethnic groups also had different mean costs of care. Hispanic and black patients had mean health care costs that were more than $5,000 higher than the costs of white patients (Online Figure 2 ). There were also differences in mean health care costs by comorbid conditions ( Table 3) . Patients diagnosed with comorbid drug use disorders had the highest reported costs of VA care. Other behavioral diagnoses (alcohol use disorders, depression, post-traumatic stress disorder, and other psychiatric disorders) were also associated with higher mean costs compared with patients without these comorbid conditions. Health care costs were also relatively high for patients with renal failure.
In adjusted analyses predicting total VA health care costs using both patient factors and facility, patient factors explained more of the variation in health care costs compared with the facility where the patient was treated ( Table 4 In the fully adjusted model, older age was significantly associated with lower costs (p < 0.001). Black patients had 5% higher costs than whites (p < 0.001).
Currently single marital status, higher service connection, and no other insurance were also significantly associated with higher costs (all p < 0.001).
All comorbid conditions were associated with higher Values are mean AE SD.
Abbreviations as in Table 1 . Abbreviations as in Table 1 .
factors such as being black or Hispanic, being unmarried, and being more likely to have a serviceconnected disability were also associated with higher costs. These characteristics have been found previously to be associated with relatively more VA utilization and less non-VA utilization (24), so higher costs can represent worse health status and greater need for care or greater reliance on VA providers for health care. Patients in their last year of life also had considerably higher costs than patients who were not, which was expected given the rising demand for care
at the end of life.
A majority of VA costs for HF patients were attributed to inpatient health care, and most of this was due to medical/surgical care with patients having a mean number of 1 hospitalization during the year.
HF patients also had a substantial amount of costs from outpatient care for medical/surgical, pharmacy, and diagnostic care. Patients had both frequent primary care and specialty care visits during the year. All parameters in the table were statistically significant at p < 0.001. Incident rate ratios were obtained from generalized linear regression models with a Poisson family distribution and log-link function. Incident rate ratios represent the percent change in costs associated with a 1-unit change in continuous variable or the percent change in costs relative to the reference category for categorical variables. Coefficients from facility dummies in models 2 and 3 are not shown.
Abbreviations as in Table 1 .
Yoon et al. There was significant variation in costs by VA facility where patients were treated. Although differences in costs between patients were mostly explained by patient factors, the wide variation between facilities suggests some opportunities to improve resource utilization in high-cost facilities.
Previous research found that quality of care indicators varied across non-VA hospitals for HF patients, and several provider and hospital characteristics have been associated with treatment differences and costs (7, 8, 30 and facility variation in costs may be either underestimated or overestimated by not including non-VA costs of care. In this study, we presented costs over a 1-year period; however, the pattern in cost variation may be different over multiple years. Another limitation in this study is that we were not able to measure severity of HF across patients with our data, so it is possible that other patient factors were confounded with unmeasured severity and that VA facilities with more severely ill patients also had higher average costs. We did not have information on the time since diagnosis because our cohort included those newly diagnosed during the study year and those diagnosed in earlier years, so it is possible that patients newly Average adjusted costs ranged widely between facilities, from approximately $15,000 to $48,000 per patient.
